
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Lead the field market access organization, calling on payers and Treatment Centers. • Drive appropriate access and coverage for Kyverna’s portfolio across payers and Cellular Therapy Treatment Centers. • Serve as a player/coach and eventually lead a team responsible for developing and maintaining relationships with state Medicaid payers, MACs, national, and regional payers. • Ensure coverage and reimbursement for Kyverna’s therapies. • Build and execute account-specific business plans in alignment with broader market access and brand strategies. • Deliver compelling value propositions and payer materials customized to each stakeholder’s needs. • Track and report market trends, competitive intelligence, policy changes, and access barriers. • Collaborate on the development of performance KPIs and metrics to evaluate access success and account performance.
• Bachelor's degree required; advanced degree preferred. • 12+ years of progressive experience in the pharmaceutical or biotech industry with 10+ years in market access, including field and / or strategy roles. • 5+ years of people leadership experience. • Rare disease or oncology cellular therapy experience required; buy & bill experience required. • Cell or Gene Therapy experience preferred. • Deep understanding of: • Commercial payers (national and regional) and approach to medical policy decision-making. • Medicaid policy development • CMS protocols and applications (NTAP,DRG, Q/J-code, etc.) • Reimbursement and patient pull-through • Coding and billing requirements • P&T process for high cost drug therapies • Demonstrated success in building and managing relationships with payers and financial decision-makers in Treatment Centers. • Proven record of existing relationships with payers and financial decision-makers. • Strategic thinking with a collaborative mindset and ability to influence cross-functional teams, with unique persistence in driving patient access to complex medicines. • Excellent communication, presentation, and negotiation skills. • Proficiency with CRM/COS systems, PowerPoint, and Excel.
• eligible for bonus • benefits • participation in Company’s stock plan
Apply Now🔥 1 hour ago
Associate Director leading technology solutions for Humana’s healthcare services. Managing technology initiatives and collaborating across teams to enhance member experience and compliance.
🔥 1 hour ago
Senior Strategic Alliances Director leading and scaling global partnership with Amazon at Coupa. Driving AWS Marketplace performance and co-sell execution for revenue growth.
🔥 4 hours ago
Associate Director managing Market Access Portfolio Strategy for Novartis. Focus on understanding US Market Access landscape and informing business strategy over a long-term horizon.
🇺🇸 United States – Remote
💵 $160.3k - $297.7k / year
💰 Debt Financing on 2005-12
⏰ Full Time
🟠 Senior
👔 Director
🔥 5 hours ago
Associate Director, US Commercial Insights defining US insights strategy and driving actionable recommendations for rheumatology team. Partnering with commercialization and leadership across the organization.
🔥 7 hours ago
10,000+ employees
Director of Clinical Development managing clinical programs and trials at BeOne. Collaborating across teams to ensure best-in-class execution and efficient resource management.